CervoMed Inc. (CRVO) AI Dilution Summary

CRVO funds itself through its active ATM with Leerink Partners LLC, authorised to $50,000,000; the most recent capital raised was ATM sales through 2026-06-30, with 550,000 shares sold since the program began and sales after 2026-06-30 not yet reported. Estimated cash was $22,633,623 as of 2026-07-31, from $24,938,172 at 2026-06-30, against estimated monthly burn of $2,306,142. Dilution here is driven primarily by the ATM's $45,300,000 of remaining capacity.